148 related articles for article (PubMed ID: 10234996)
1. Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707.
Macdonald RL; Johns L; Lin G; Marton LS; Hallak H; Marcoux F; Kowalczuk A
Neurol Med Chir (Tokyo); 1998; 38 Suppl():138-45. PubMed ID: 10234996
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM
J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
[TBL] [Abstract][Full Text] [Related]
4. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.
Stoodley M; Weihl CC; Zhang ZD; Lin G; Johns LM; Kowalczuk A; Ghadge G; Roos RP; Macdonald RL
Neurosurgery; 2000 May; 46(5):1193-202; discussion 1202-3. PubMed ID: 10807252
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
Zimmermann M; Seifert V
Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274
[TBL] [Abstract][Full Text] [Related]
6. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
Macdonald RL; Bassiouny M; Johns L; Sajdak M; Marton LS; Weir BK; Hall ED; Andrus PK
Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
[TBL] [Abstract][Full Text] [Related]
8. The role of endothelin in experimental cerebral vasospasm.
Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
[TBL] [Abstract][Full Text] [Related]
9. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
[TBL] [Abstract][Full Text] [Related]
10. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
Ohkuma H; Parney I; Megyesi J; Ghahary A; Findlay JM
J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
[TBL] [Abstract][Full Text] [Related]
11. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys.
Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM
Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140
[TBL] [Abstract][Full Text] [Related]
12. Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage.
Ahmad I; Imaizumi S; Shimizu H; Kaminuma T; Ochiai N; Tajima M; Yoshimoto T
Acta Neurochir (Wien); 1996; 138(10):1230-40. PubMed ID: 8955444
[TBL] [Abstract][Full Text] [Related]
13. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists.
Zuccarello M; Soattin GB; Lewis AI; Breu V; Hallak H; Rapoport RM
J Neurosurg; 1996 Mar; 84(3):503-7. PubMed ID: 8609565
[TBL] [Abstract][Full Text] [Related]
14. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
Alexander E; Black PM; Liszczak TM; Zervas NT
J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
[TBL] [Abstract][Full Text] [Related]
15. Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model.
Kita T; Kubo K; Hiramatsu K; Sakaki T; Yonetani Y; Sato S; Fujimoto M; Nakashima T
Life Sci; 1998; 63(4):305-15. PubMed ID: 9698039
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia.
Patel TR; Galbraith S; Graham DI; Hallak H; Doherty AM; McCulloch J
J Cereb Blood Flow Metab; 1996 Sep; 16(5):950-8. PubMed ID: 8784239
[TBL] [Abstract][Full Text] [Related]
17. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs.
Nirei H; Hamada K; Shoubo M; Sogabe K; Notsu Y; Ono T
Life Sci; 1993; 52(23):1869-74. PubMed ID: 8318117
[TBL] [Abstract][Full Text] [Related]
18. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm.
Cosentino F; McMahon EG; Carter JS; Katusić ZS
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S332-5. PubMed ID: 7509979
[TBL] [Abstract][Full Text] [Related]
19. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm.
Shigeno T; Clozel M; Sakai S; Saito A; Goto K
Neurosurgery; 1995 Jul; 37(1):87-90; discussion 90-1. PubMed ID: 8587696
[TBL] [Abstract][Full Text] [Related]
20. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
